Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students

Journal of Epidemiology and Community Health

Volumn 66, Issue 11, 2012, Pages 990-994

  Brière, Frédéric N ^a   Fallu, Jean Sébastien ^a   Janosz, Michel ^a   Pagani, Linda S ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CENTRAL STIMULANT AGENT; METHAMPHETAMINE; STREET DRUG;

ADOLESCENCE; DRUG; EPIDEMIOLOGY; HEALTH RISK; MENTAL HEALTH; NEUROLOGY; REGRESSION ANALYSIS; RESEARCH WORK; STUDENT; TOXICITY; VULNERABILITY;

ADOLESCENT; ARTICLE; CANADA; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG ABUSE; FEMALE; HUMAN; MALE; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICAL MODEL; STUDENT;

ADOLESCENT; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREVALENCE; PROSPECTIVE STUDIES; QUEBEC; SOCIOECONOMIC FACTORS; STREET DRUGS; STUDENTS;

CANADA; QUEBEC [CANADA];

EID: 84868638020     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2011-200706     Document Type: Article

References (34)

1. Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics 1997;100:705-8.
2. Degenhardt L, Barker B, Topp L. Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 2004;99:187-95.
3. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future National Survey Results on Drug Use, 1975-2008: Volume I, Secondary School Students (NIH Publication No. 09-7402). Bethesda, MD: National Institute on Drug Abuse, 2009.
4. Pederson W, Skrondal A. Ecstasy and new pattern of drug use: a normal population study. Addiction 1999;94:1695-706.
5. Clemens KJ, McGregor IS, Hunt GE, et al. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 2007;26:9-15.
6. Gouzoulis-Mayfrank E, Daumann J. Neurotoxicity of drugs of abuse-the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci 2009;11:305-17.
7. Sumnall HR, Cole JC. Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis. J Psychopharmacol 2005;19:84-92.
8. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004;13:181-90.
9. Parrott AC, Buchanan T, Scholey AB. Ecstasy/ MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 2002;17:309-12.
10. Dahl RE. Adolescent brain development: a period of vulnerabilities and opportunities. Keynote address. Ann N Y Acad Sci 2004;1021:1-22.
11. Geller B, Zimerman B, Williams M, et al. Adult psychosocial outcome of prepubertal major depressive disorder. J Am Acad Child Adolesc Psychiatry 2001;40:673-7.
12. Degenhardt L, Coffey C, Moran P, et al. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction 2007;102:1076-84.
13. Lieb R, Schuetz CG, Pfister H, et al. Mental disorders in ecstasy users: a prospectivelongitudinal investigation. Drug Alcohol Depend 2002;68:195-207.
14. Yen CF, Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry 2006;47:215-20.
15. Sutcliffe CG, German D, Sirirojn B, et al. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend 2009;101:146-51.
16. Cole JC, Bailey M, Sumnall HR, et al. The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 2002;97:1531-6.
17. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
18. Radloff LS. The use of the Center for Epidemiologic studies depression scale in adolescents and young adults. J Youth Adolesc 1991;20:149-66.
19. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
20. Archambault I, Janosz M, Pagani L, et al. The multidimensionality of student engagement and its predictive relationship to high school dropout. J Adolesc 2009;32:651-70.
21. Spence SH. Structure of anxiety symptoms among children: a confirmatory factoranalytic study. J Abnorm Psychol 1997;106:280-97.
22. Le Blanc M, McDuff P, Fréchette M. Manuel Sur Des Mesures de l'adaptation Sociale et Personnelle Pour Les Adolescents Québécois. Montréal: Université de Montréal, Groupe de recherche sur l'inadaptation psychosociale chez l'enfant, 1994.
23. Raven JC, Court JH, Raven J. Standard Progressive Matrices. Oxford: Oxford Psychologists Press, 1996.
24. John OP. The "Big Five" factor taxonomy: dimensions of personality in the natural language and in questionnaires. In: Pervin LA, ed. Handbook of Personality: Theory and Research. New York: Guilford press, 1990:66-100.
25. MacDonald KB. Effortful control, explicit processing, and the regulation of human evolved predispositions. Psychol Rev 2008;115:1012-31.
26. Ganzeboom HBG, de Graff P, Treiman DA. Standard international socio-economic index of occupational status. Soc Sci Res 1992;21:1-56.
27. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol 2009;60:549-76.
28. Schafer JL. Analysis of Incomplete Multivariate Data. New York: Chapman & Hall, 1997.
29. Muthén LK, Muthén BO. Mplus User's Guide. Sixth Edition. Los Angeles, CA: Muthén & Muthén, 1998-2010.
30. Reneman L, Booij J, de Bruin K, et al. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001;358:1864-9.
31. Parrot AC. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 2006;20:147-63.
32. Hayatbakhsh MR, Najman JM, Jamrozik K, et al. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 2007;46:408-17.
33. Rey JM, Sawyer MG, Raphael B, et al. Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry 2002;180:216-21.
34. Barnea Z, Rahav G, Teichman M. The reliability and consistency of self-reports on substance use in a longitudinal study. Br J Addict 1987;82:891-8.